Knoll Inc (KNL) Jumps 7.25% on February 15

Equities Staff |

Knoll Inc (KNL) was among the biggest gainers on the Russell 2000 for Monday February 15 as the stock popped 7.25% to $18.20, representing a gain of $1.23 per share. Some 772,583 shares traded hands on 6,115 trades, compared with an average daily volume of 295,432 shares out of a total float of 48.83 million. The stock opened at $17.82 and traded with an intraday range of $18.94 to $17.82.

After today's gains, Knoll Inc reached a market cap of $888.64 million. Knoll Inc has had a trading range between $26.06 and $16.42 over the last year, and it had a 50-day SMA of $18.77 and a 200-day SMA of $22.17.

The stock has a P/E Ratio of 12.7.

Knoll Inc along with its subsidiaries is engaged in the design, manufacture and sale of furniture products and accessories, modern outdoor furniture. It is also engaged in the sale of fine leather, and textiles.

Knoll Inc is based out of East Greenville, PA and has some 3,343 employees. Its CEO is Andrew B. Cogan.

For a complete fundamental analysis analysis of Knoll Inc, check out’s Stock Valuation Analysis report for KNL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…